These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 32247038)

  • 1. Potential effect of blood purification therapy in reducing cytokine storm as a late complication of critically ill COVID-19.
    Ma J; Xia P; Zhou Y; Liu Z; Zhou X; Wang J; Li T; Yan X; Chen L; Zhang S; Qin Y; Li X
    Clin Immunol; 2020 May; 214():108408. PubMed ID: 32247038
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful recovery of severe COVID-19 with cytokine storm treating with extracorporeal blood purification.
    Wang Q; Hu Z
    Int J Infect Dis; 2020 Jul; 96():618-620. PubMed ID: 32470601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of plasma exchange in association with higher dose CVVH in Cytokine Storm Complicating COVID-19.
    Lin JH; Chen YC; Lu CL; Hsu YN; Wang WJ
    J Formos Med Assoc; 2020 Jun; 119(6):1116-1118. PubMed ID: 32359878
    [No Abstract]   [Full Text] [Related]  

  • 4. Extracorporeal blood purification treatment options for COVID-19: The role of immunoadsorption.
    Yiğenoğlu TN; Ulas T; Dal MS; Korkmaz S; Erkurt MA; Altuntaş F
    Transfus Apher Sci; 2020 Aug; 59(4):102855. PubMed ID: 32636114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expert consensus on special blood purification technics in patients with corona virus disease 2019].
    ;
    Zhonghua Nei Ke Za Zhi; 2020 Nov; 59(11):847-853. PubMed ID: 32521580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients.
    Tabibi S; Tabibi T; Conic RRZ; Banisaeed N; Streiff MB
    J Intensive Care Med; 2020 Sep; 35(9):827-835. PubMed ID: 32666875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hazards of the Cytokine Storm and Cytokine-Targeted Therapy in Patients With COVID-19: Review.
    Quirch M; Lee J; Rehman S
    J Med Internet Res; 2020 Aug; 22(8):e20193. PubMed ID: 32707537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients?
    Chen G; Zhou Y; Ma J; Xia P; Qin Y; Li X
    Ren Fail; 2020 Nov; 42(1):483-488. PubMed ID: 32438839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Pandemic Hemoperfusion Therapy Versus Plasma Exchange Therapy in Intensive Care.
    Esmaeili Vardanjani A; Moayedi S; Golitaleb M
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):7-9. PubMed ID: 32534513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of extracorporeal blood purification (hemoadsorption) in patients with severe coronavirus disease 2019 (COVID-19).
    Asgharpour M; Mehdinezhad H; Bayani M; Zavareh MSH; Hamidi SH; Akbari R; Ghadimi R; Bijani A; Mouodi S
    BMC Nephrol; 2020 Aug; 21(1):356. PubMed ID: 32819292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic plasma exchange in life-threatening COVID-19 and associated cytokine release syndrome.
    Faqihi F; Alharthy A; Karakitsos D
    J Formos Med Assoc; 2020 Dec; 119(12):1888-1889. PubMed ID: 32680687
    [No Abstract]   [Full Text] [Related]  

  • 13. Can mesenchymal stem cell therapy be the interim management of COVID-19?
    Bamba C; Singh SP; Choudhury S
    Drug Discov Ther; 2020 Jul; 14(3):139-142. PubMed ID: 32554953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal Hemoadsorption: An Option for COVID-19-Associated Cytokine Storm Syndrome.
    Napp LC; Bauersachs J
    Shock; 2020 Nov; 54(5):700-701. PubMed ID: 32453251
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts.
    Wang J; Jiang M; Chen X; Montaner LJ
    J Leukoc Biol; 2020 Jul; 108(1):17-41. PubMed ID: 32534467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019].
    Chen C; Zhang XR; Ju ZY; He WF
    Zhonghua Shao Shang Za Zhi; 2020 Jun; 36(6):471-475. PubMed ID: 32114747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel treatment approach to the novel coronavirus: an argument for the use of therapeutic plasma exchange for fulminant COVID-19.
    Keith P; Day M; Perkins L; Moyer L; Hewitt K; Wells A
    Crit Care; 2020 Apr; 24(1):128. PubMed ID: 32241301
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
    Yang X; Yu Y; Xu J; Shu H; Xia J; Liu H; Wu Y; Zhang L; Yu Z; Fang M; Yu T; Wang Y; Pan S; Zou X; Yuan S; Shang Y
    Lancet Respir Med; 2020 May; 8(5):475-481. PubMed ID: 32105632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CytoResc - "CytoSorb" Rescue for critically ill patients undergoing the COVID-19 Cytokine Storm: A structured summary of a study protocol for a randomized controlled trial.
    Stockmann H; Keller T; Büttner S; Jörres A; Kindgen-Milles D; Kunz JV; Leebmann J; Spies C; Träger K; Treskatsch S; Uhrig A; Willam C; Enghard P; Slowinski T;
    Trials; 2020 Jun; 21(1):577. PubMed ID: 32586396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19.
    Shi H; Zhou C; He P; Huang S; Duan Y; Wang X; Lin K; Zhou C; Zhang X; Zha Y
    Int J Antimicrob Agents; 2020 Aug; 56(2):105974. PubMed ID: 32298745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.